Mitchell Fuerst

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
FDA has recently asserted that many autologous cell therapies once considered the practice of medicine are in fact drugs. These changes began with the creation of new sections of 21 CFR 1271 and a subsequent one word change where the FDA, without public commentary, altered a single word in its regulatory language regarding cell and tissue based therapies(More)
  • 1